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REFRACTORY HEART FAILURE 
ELLET H . DRAKE, M.D.* 
Patients with congestive heart failure will show considerable variation in their 
individual response to the conventional therapeutic methods. Moreover, a specific 
patient will vary in individual responsiveness from time to time, and, under certain 
conditions, may cease to respond or actually to regress while still under intensive 
ETIOLOGIC FACTORS IM RESISTANT HEART FAILURE 
Cardiac 
1. 
2. 
5. 
k. 
5. 
6, 
7. 
9. 
Advanced cardiac disease 
Active rheumatic c a r d i t i s 
Arrhythmia 
Silent or masked myocardial i n f a r c t i o n 
Myocardial aneurysm 
Bac t e r i a l endocarditis 
Constrictive p e r i c a r d i t i s 
Unsuspected v a l v u l a r disease 
(a) Tricuspid stenosis and i n s u f f i c i e n c y 
Obscure cardiac disease 
(a) 
(b) 
(c) 
(d) 
(e) 
Myocarditis 
Amyloidosis 
Lupus erythematosis 
Polyangitis 
Fibroelastosis 
Pulmonary 
( f ) Hemochromatosis (k) 
(g) Tiunors ( l ) 
(h) Carcinoid syndrome (m) 
( i ) Sickle c e l l disease (n) 
( i ) Scleroderma (o) 
(p) 
(q) 
Dermatomyositis 
Muscular dystrophy 
Polycythemia vera 
Sarcoid 
"Idiopathic hyper." 
Marfans 
Nephritis 
1. M u l t i p l e pulmonary emboli 
2. Chronic pulmonary disease (cor pulmonale) 
5. Pulmonary thrombosis 
(a) M i t r a l stenosis 
(b) Auricular septal defect 
I+. Pulmonary A-V f i s t u l a 
5. Localized i n t e r l o b a r p l e u r a l effusion and regular ef-
fusions 
Therapeutic 
1. 
2. 
3. 
5. 
6. 
7. 
Inadequate d i g i t a l i s 
D i g i t a l i s i n t o x i c a t i o n 
Excessive sodium intake 
(a) Diet 
(b) Drinking water 
(c) Private wells 
Excessive d i u r e t i c therapy 
(a) Hypochloremic alkalosis 
(b) Hyperchloremio acidosis 
Excessive loss of s a l t 
(a) Vomiting 
(b) Diarrhea 
(o) Low s a l t d i e t 
(d) Paracentesis 
Excessive physical a c t i v i t y 
Excessive mental stress and emotional a c t i v i t y 
Blood d i l u t i o n syndrome (water i n t o x i c a t i o n ) 
Figure 1 
• Division of Cardiology. 
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Hypermetabolic 
1. -Hyperthyroidism 
2. Anemia 
3. I n f e c t i o n and r e b r i l e s t a t e s 
L i v e r d y s f u n c t i o n 
(a) Laennec's c i r r h o s i s 
(b) Cardiac c i r r h o s i s 
5. M a l n u t r i t i o n 
(a) B e r i b e r i 
( b ) Hypoproteinemia 
6. Arteriovenous communications 
(a) Systemic A-V f i s t u l a 
( b ) Paget's disease 
( c ) Chronic pulmonary disease 
Endocrine 
1. Hyperthyroidism 
2. Hypothyroidism 
3. H y p e r c o r t i c a l i s m 
(a) Exogenous 
(b) Ctishing's syndrome 
(c ) Aldosteronism ? 
^ . Pheochromocytoma 
5. P o s t e r i o r p i t u i t a r y - A . B . E . and Aldosterone 
Lowered Renal Blood Flow 
1. Severe i n t r i n s i c r e n a l disease 
2. Lowered cardiac output 
output down kOfo, R.B.P. down JOfc 
3. Renal v a s o c o n s t r i c t i o n from a n u r i a 
^ . Local mechanical 
pressure from l a r g e c o l l e c t i o n of a s c i t e s 
Figure 1 (Continued) 
therapy. In this latter state, the patient is often referred to as refractory or intractable. 
We perfer the former term because of its more optimistic connotation. I wish to 
discuss first some of the etiologic factors which are important in bringing about 
this state of relative refractiveness or resistance and then to take up some of the 
specific methods of management. 
For the sake of convenience, I wish to group the important etiologic factors 
in six categories (Figure 1). It should be emphasized that the various entities 
mentioned may, in themselves, be a specific underlying etiology for the heart disease 
or may simply be a complicating or aggravating factor which is acting in con-
junction with the basic etiology. 
First among the cardiac factors, we have listed Progression of the Underlying 
Cardiac State.' Since most heart disease leading to a state of congestive failure is 
progressive, it is logical to assume that this progression itself may eventually lead 
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to a state of refractiveness. But we should not be too quick to adopt this convenient 
explanation for a patient whose condition is deteriorating until a careful search has 
been made for other factors which may possibly be reversible. A period of 
rheumatic activity is frequently responsible for refractiveness to treatment in a 
patient with rheumatic heart disease. In addition to the common laboratory aids to 
diagnosis and the EKG, the onset of auricular fibrillation, and the appearance of 
low-grade fever may be a tipoff that rheumatic activity is present. Arrhythmias and 
atypical myocardial infarcts will often cause exacerbations of failure and should 
constantly be kept in mind. Figure 2 shows the x-ray of a man who had gone into 
Figure 2 
Distortion of the left lateral heart border is due to the presence of a large ventricular aneurysm. 
marked congestive failure several months after a rather severe myocardial infarct 
and whose condition was one of progressive deterioration despite the use of all 
available medical measures. A myocardial aneurysm was suspected clinically, and 
despite the fact the fluoroscopic examination was not entirely confirmatory, the 
patient was subjected to radical surgery for removal of the useless muscle despite 
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his critical state. At operation, a large part of the ventricular wall which included 
the aneurysm was resected with a resulting improvement in his state of compensation. 
Bacterial endocarditis should always be kept in mind in patients with valvular lesions 
whose failure is not responding to treatment, especially in those patients in the older 
age groups who have lesions of the aortic valve. Fever will often not be a 
prominent part of the picture, and the offending organism must be diligently sought 
for especially in those cases where prophylactic antibiotics are being given to prevent 
pulmonary infection as a result of stasis. In those patients in whom a right sided 
lesion is a possibility, cultures of pulmonary artery blood, taken by a catheter, 
should be considered. Constrictive pericarditis is sometimes difficult to diagnose, but 
the gratifying response which follows a successful surgical treament in a patient 
not responding to digitalis and other medical measures makes it well worth the 
effort to keep this condition constantly in mind. It is not necessary that the patient 
have a small cardiac shadow on x-ray or that the pulsations necessarily be abolished 
over the entire heart border for this lesion to be present. Patients with previous 
cardiac hypertrophy and those with associated pericardial effusions may show con-
siderable enlargement to x-ray and physical examination, and the offending con-
stricting band may involve only a small segment of the heart surface. Among 
unsuspected valvular lesions, those of the tricuspid valve may be especially trouble-
some. They may account for the lack of an effective response in a patient who has 
undergone a successful mitral commissurotomy. For the sake of completeness, we 
have listed several obscure cardiac diseases which may lead to conditions of resistant 
failure. Some of these involve the heart primarily, such as fibroelastosis and primary 
amyloidosis. Others may affect the heart indirectly such as sickle cell disease while still 
CONGEStlVE HEART-FAItURE 
ADH 
AIDOStERONE 
FICURE3. Conditions associated wilh congestive heart-Iailure. 
Figure 3 
FAItURE OF DIURESIS 
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others may do both such as Marfans which may not only produce valvular lesions but 
also contribute toward the intractability of failure by destroying the normal elasticity 
of the aorta. 
Many hypermetabolic states are important aggravating factors leading toward 
resistant congestive heart failure. Latent hyperthyroidism should be suspected in any 
patient in whom fibrillation does not respond satisfactorily to Digitalis, who shows 
bouts of transient glycosuria, or in whom the complexion is pink in contrast to the 
usual sallow washed-out complexion of the cardiac in failure. Protein bound iodine 
determinations and uptake studies will help to confirm or deny such a clinical opinion. 
Anemia, regardless of the cause, will aggravate congestive failure if the hemoglobin 
value falls to a range of 60% or less. Infections and febrile states are extremely 
important both in precipitating bouts of congestive failure and in contributing to 
a state of refractiveness. In a recent series of 300 cases of congestive failure ad-
mitted to a British hospital, respiratory disease was present in 167 cases and was 
the precise cause of failure in 156 cases.^  It was especially important in older 
people. The role of the liver in congestive failure is a complex one. Figure 3 will 
illustrate some of the possible pathways by which it plays a part in contributing to 
a refractory state. Arterio-venous communications with their associated many-fold 
increase in circulating blood volume add an additional load to the heart which 
cannot be successfully combated by specific treatment directed toward cardiac 
function alone. Multiple pulmonary emboli are responsible for a resistant or 
refractory state in many cardiacs undergoing therapy for congestive failure and 
thrombosis of a major vessel is not an unusual terminal event in patients suffering 
from mitral stenosis or intracardiac shunts. Large localized fluid collections will 
seriously impair cardiac function in the failing patient and should be removed 
wherever possible. 
ACETYL STROPHANTHIDIN TEST 
1. Dilute 1.2 mgm. (2 amps.) of the material to 20 cc. 
i n 5?^  glucose and H^ O. 
2. In the presence of an arrhythmia possibly due to 
d i g i t a l i s give K f i r s t . 
3. Run s t r i p of EKG p r i o r to each i n j e c t i o n . 
k. Give 5 cc. of the d i l u t i o n every 5 min. u n t i l either 
evidence of therapeutic effect or mild toxic e f f e c t s , 
( i f i n t o x i c a t i o n suspected either 
a. Increase i n t e r v a l to 10 min. - or 
b. Reduce f i r s t two doses to .15 mgm. (2.5 c c ) . 
Int e r p r e t a t i o n 
1. I f t o x i c i t y a f t e r 1st i n j e c t i o n presume overdosage. 
2. I f t o x i c i t y a f t e r .6 mgm. then d i g i t a l i z a t i o n adequate. 
3. I f therapeutic effect a f t e r .6, ,9» or 1.2 mgm. then 
give proportional doses of longer acting preparations. 
Figure 4 
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It is somewhat ironic that many therapeutic measures may, in themselves, con-
tribute to resistance in the patient with cardiac failure. Often it is very difficult to 
tell clinically whether a patient with nausea, vomiting and an arrhythmia may be 
suffering these manifestations on the basis of the congestive failure alone or whether 
he may be over digitalized. Figure 4 shows the details of the acetyl strophanthidin 
test which, while not without its dangers, may sometimes be justifiably employed 
to determine the status of digitalization.^ If over digitalization is suspected, potassium 
should be administered prior to the test and the dosage should be reduced as 
indicated. Excessive intake of sodium is not often overlooked in treating the patient 
with congestive failure, but I would like to call attention to the possible hazards 
existing to the patient who obtains his drinking water from a private well. Many 
of these are quite high in sodium content. Water softeners may also present a 
similar hazard and either of these two potential sources of sodium may explain the 
reason why a patient will do well while hospitalized and then rapidly slip back to 
failure when he returns to his home. 
Certain metabolic factors should be mentioned briefly. Hyperthyroidism has 
been discussed previously and is included here only for completeness. It is doubtful 
whether hypothyroidism may, in itself, be actually the cause for their congestive 
failure, though some patients made artificially myxedematous in the treatment of 
angina pectoris develop large pericardial effusions which may actually seriously 
impair myocardial efficiency. Excessive adrenocortical activity may either be of 
an exogenous nature or occur with a Cushing's syndrome. There is conceded to be 
some adrenal autonomy in the production of aldosterone although this substance 
may, of course, also result from increased posterior pituitary activity acting through 
the adrenal cortex. Aldosterone secretion is influenced by the volume of body fluids 
and any reduction of extracellular volume occurring with bleeding, drainage of 
ascitic fluids, salt depletion and so forth, will increase its production. 
Lowered renal blood fiow will be found in cases complicated by severe intrinsic 
renal disease which may not be amenable to therapy, but it may also occur in states 
of lowered cardiac output, renal vasoconstriction from anuria, and as a result of 
local mechanical pressure from a large collection of acities or other conditions 
potentially reversible. 
In discussing some of the specific methods of management of a case of re-
fractory failure, the question of disordered electrolyte metabolism, which may aften 
be found in these states, must be considered.Figure 5 shows the usual "electrolyte 
patterns" which are said to result from congestive failure alone or secondary to its 
treatment. I bring these to your attention primarily to point out that the clinical 
manifestations of the various syndromes are quite similar and I seriously question 
whether they can be diagnosed on that basis alone. Moreover, chemical determinations 
will not be conclusive except in a few instances, since they do not supply necessary 
information to allow complete separation of dilution and depletion states. The dilution 
syndrome will often be found to develop spontaneously in patients with congestive failure 
while sodium depletion and hypochloremic alkalosis are often the result of the in-
tensive administration of diuretics, particularly mercurials. In practice, these specific 
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KLECTROLYTK PATTERNS IN 
RESI5TAMT COKGESTIVE FAILURE 
Sodium D e p l e t i o n 
"Low S a l t Syndrome" 
" D i l u t i o n SjTidroBe" 
(May develop apon t -
aneously i n CHP 
w i t h c o n s e r v a t i T e 
naaagement). 
H jpooh lo re in i c 
l l l c a l o s i a 
R e s p i r a t o r y 
A c i d o s i s 
Hyperohloremic 
A c i d o s i s 
Na 
Cl 
B i c a r b . 
Azotemia 
Acidoaia 
Na I 
Cl \J/ 
( T o t a l body 
atorea 
normal o r 
increaaed) 
azotemia 
B i o s r b . t 
a l k a l o a i a 
SaiBe w i t h 
a c i d o s i s 
Cl /JS 
I 
Bicarb .Nl/ 
Cause 
Low Na I n t a k e 
D i u r e a i a 
Diarrhea 
Sweating 
Thoracentesis 
Paracentesis 
Low Na I n t a k e 
U n r e s t r i c t e d 
f l u i d s 
Reduced r e n a l 
f u n c t i o n 
A n t i - d i u r e t i c 
hormone 
D i u r e t i c s 
a n o rexia 
v o m i t i n g 
Always aaaoc. 
w i t h pulmonary 
diaeaae. 
CO r e t e n t i o n 
Exchange 
Heains 
Diamox 
NE and Cl 
Usua l l y r e n a l 
diaeaae 
C U n i c a l 
Anorexia 
Nauaea and vom. 
Apathy drowsiness 
Res tlessnees 
Confusion, coma 
Muscular weakness 
Cramps 
I n s i d i o u s onset 
Apathy 
Anorexia 
Nauaea and vom. 
Drowsiness 
Psychoeis 
Confusion, coma 
Apathy 
Anorexia 
Weakneaa 
Drowsiness 
Mental c o n f u s i o n 
Hyperpnea 
Stupor 
Coma 
Therapy 
S a l t by mouth 
Cone, s a l i n e IV 
200 cc b.d. 
Ri - a c i d o s i s 
B i c a r b . 
l a c t a t e 
1£. 
Res t r i o t 
f l u i d s 
C h l o r i d e 
o r a l l y IV 
i n 5^ glucose 
(Not over 
100 oo i n 
1 hour or 
1500 oc 
per day) 
K. and Ca. 
Diamox 
M e r c u r i a l 
D i u r e t i c s 
A l k a l i n e 
Sod. S a l t s 
Figure 5 
PRACTICAL PROGRAM FOR PATIENT 
REFRACTORY TO DIURETICS 
le Ease up on the d i u r e t i c therapy. 
2m Search again for factors which may aggravate f a i l u r e 
a, Hypoproteinemia 
b. Hydrothorax and a s c i t e s . 
3. Avoid d i r e c t attack on e l e c t r o l y t e s when c l i n i c a l 
condition of the patient i s s a t i s f a c t o r y . 
km Re-evaluate the p o s s i b i l i t y of surgery i n e l i g i b l e 
cases. 
5* Give potassium (even i f blood l e v e l s are not low). 
Give 3-^ grams d a i l y . This may produce d i u r e s i s and 
r i s e i n sodium. 
6. Try the "Rubin Regime." 
7. Hypertonic s a l t solution. 
8. Massive s t e r o i d therapy 
Figure 6 
syndromes that are so glibly described in the literature, are often difficult to differentiate 
although we might make one or two generalizations. Most patients with congestive 
heart failure and hyponatremia do not have a true sodium depletion syndrome and will 
not benefit from the administration of concentrated salt/ Moreover, the unfavorable 
clinical situation associated with electrolyte disturbance is more often not due to the 
electrolyte disturbance itself, but rather to a resuh of the progression of the heart 
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"RUBIN REGIME" 
E f f e c t i v e both f o r p a t i e n t s w i t h 
normal e l e c t r o l y t e p a t t e r n s and 
those w i t h c h l o r i d e d e p l e t i o n . 
1. Diamox d a i l y f o r 3 - ^  days. 
2. Then - add 10 grams of ammonium 
c h l o r i d e d a i l y f o r 5 - ^  days. 
3. Stop diamox but continue ammonium 
c h l o r i d e . 
k . Give p a r e n t e r a l mercury 48 hours 
a f t e r d i s c o n t i n u i n g the diamox. 
Figure 7 
disease and its complications. In Figure 6 we have presented a practical program for 
approaching these patients with electrolyte disturbances that cannot be readily pinned 
down as fitting into one or another of the syndrome patterns. Point six refers to the 
"Rubin Regime" which is detailed in Figure 7 and 8. This program has repeatedly 
given satisfactory results in our hands, often restoring the response to diuretics and 
markedly improving the basic failure state. The patient should be watched for ex-
cessive acidosis during the time it is administered. Aminophyline may often be used 
successfully to augment the effect of mercurists. It may be safely administered in 0.5 
gram doses diluted to 250 cc. in 5% dextrose, the entire injection made over a 30 
minute period, beginning about three hours after the injection of the mercurial.' 
ANTICOAGULANTS IN RESISTANT 
CONGESTIVE FAILURE 
Thromboemboli found i n 3O/0 of p a t i e n t s dying of 
CHP. I n many they are the d i r e c t cause. 
I n d i c a t i o n s 
1. Rheumatic heart disease w i t h emboli. 
2. Thrombophlebitis 
Consider also i n 
1. Massive l e g edema w i t h or with o u t areas 
of i n f l a m m a t i o n and i n d u r a t i o n . 
2. I n c r e a s i n g dyspnea d u r i n g the course of 
congestive heart f a i l u r e . 
3. Appearance of i c t e r u s . 
Method 
Depression of prothrombin a c t i v i t y t o 
s a t i s f a c t o r y f o r p r o p h y l a x i s . Lower i f 
a c t u a l c l o t t i n g present. 
Good a n t i c o a g u l a n t s e r v i c e a "must." 
Figure 8 
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Edema in the cardiac patient may often be due in part to a severe state of 
hypoproteinemia which, for obvious reasons, cannot be successfully combated by 
dietary intake. Intranveous salt poor albumin may give temporary benefit but this 
is an expensive measure. We have had considerable success with tube feeding, using 
small polyetheline tubes through which the food mixture is forced by a "Barron pump." 
A complete meal is first prepared in a colloid mill and administered over a several 
hour period, the tube being placed in the duodenum if absorption or vomiting is a 
problem."'" The feedings on the whole are well tolerated, and the procedure may be 
adopted for home use employing a blender or even an ordinary kitchen mixer provided 
the feeding is strained prior to its passage through the pump. The small bore of the 
polyethelene tube makes it extremely well tolerated for long periods of time. 
Thromboemboh are found in 30% of patients dying of congestive heart failure 
and in many of these, they are the direct cause of the demise. This has resulted in 
expanding the indications for the use of anticoagulants to include not only those 
1-131 IN RESISTANT CONGESTIVE FAILURE 
Rationale 
1. Reduction i n metabolism means reduction i n 
cardiac work. 
2. May decrease s e n s i t i v i t y of CV system to 
adrenergic mediators. 
3. May cause a l t e r a t i o n i n pain perception. 
k. May increase rate of development of i n t e r -
coronary c o l l a t e r a l s . 
5. (Raab) Thyroid hormone effects the myocardial 
metabolism by potentiating hypoxia producing, 
calorigenic and toxic action of the adreno-
sympathogenic c o r t i c a l amines. 
Selection must have 
1. Severe disease. 
2. Been unsuccessful on medical program. 
3. Not i n moribund state. 
Dosage 
1. Bluugart - 15 mc. stat , then 2 subsequent 
doses at weekly intervals each 5 mc. larger, 
2. Jaffe - 6 mc. per week for 5-6 weeks. 
Results 
Blumgart Jaffe 
2kio s t r i k i n g l y improved 53i^ excellent 
30> worthwhile 33'/^  good 
kG^ fo no benefit l^vo not good 
Figure 9 
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patients with thrombophlebitis or rheumatic heart disease with emboli but also 
other cases with massive latent edema with or without areas of inflammation and 
induration and even to some patients with increasing dyspnea during the course of 
congestive failure or those who show the presence of icterus. Depression of the 
prothrombin activity to 45% is satisfactory for prophylaxis, and this may be depressed 
further if actual clotting is present. A satisfactory anticoagulant service should be 
available before such therapy is undertaken. (Figure 8) 
Over the past ten years, various clinics have evaluated the usefullness of 1-131 
in severe angina pectoris and to a lesser extent its use in congestive failure."-"'''' 
Figure 9 outlines the method in which this may be used and the results which have 
been obtained in two of the larger centers. 
Our own results with congestive failure are much less satisfactory than those 
achieved in angina pectoris. The unpleasant side reactions associated with this therapy 
considerably limits its usefullness and are a source of concern both to the patient 
and his relatives. It is mandatory that the patient's status be stabilized before instituting 
treatment, and it should be borne in mind that the basis underlying disease process 
is not effected by this treatment. No single dose larger than 20 millicures should be given 
in order to avoid thyroiditis. We have previously pointed out that 1-131 should not be 
administered to a patient receiving anticoagulants since the isotope acts by producing 
a hemorrhagic necrosis of the gland." 
Recently, the use of the steroids in the management of resistant heart failure has 
received considerable play in the literature." " We normally think of the steroids as 
promoting salt retention and, therefore, contra-indicated in this situation, but actually 
they may be employed profitably in certain instances to promote water diuresis. Some 
of the possible theories of their action are listed in Figure 10. The diuresis following 
the use of steroids is somewhat unpredictable as to its time of occurrence. In some 
instances, it may not occur until after the drug is stopped, but usually it takes place 
USE OF STEROIDS IN THE 
MANAGEMENT OF RESISTANT HEART FAILURE 
Rationale - (Theories) 
1. Increase glomerular f i l t r a t i o n rate. 
2. I n h i b i t a n t i - d i u r e t i c hormone. 
3. Suppression of secondary aldosteronism. 
k . Re-potentiation of d i u r e t i c drugs. 
5. Anti-inflammatory action as i n 
rheumatic heart disease. 
Dosage (not well standardized) 
Prednisone - 7.5-25 mgm./day 
1. Keep i n mind associated disorders 
e.g. - ulcers, i n f e c t i o n , tbc. 
2. Continue the basic cardiac therapy. 
Figure 10 
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after 5 to 6 days of administration. In the cases presented by Mickerson and Swale," 
the serum sodium concentration was uniformly decreased before the institution of 
steroid therapy and increased and remained at normal level despite a profuse diuresis. 
It is noted that two of their patients died of pulmonary embolism after one and two 
weeks of Prednisalone therapy respectively. The usual hazards associated with steroid 
administration such as ulcers, infection and so forth, are to be kept in mind, and the 
basic cardiac therapy should be continued during their administration. 
We have not had any extensive experience with the use of aldosterone antagonists 
and what Ihtie use we have made of them has been somewhat disappointing. Recent 
information indicates that the dosage should be revised upwards to 1200 or 1500 mg. 
a day and this is quite an expensive proposition considering the present market price 
of the available products. The manufacturers of one preparation (Aldactone)* claim 
a true synergistic reaction with conventional diuretics and advice the concurrent use of 
a mercurial or thiazide preparation. Aldactone apparently does not cause potassium 
secretion and may even offset the potassium loss induced by mercurials or thiazide 
preparations when used in combination with them. Further work will be necessary 
to evaluate these products and place them in their proper perspective in regard to the 
treatment of the patient with refractory congestive heart failure. Finally, a word 
should be said in regard to the removal of localized deposits of fluid in the 
edematous cardiac. This is easily accomplished in the case of hydrothorax or ascites 
but presents a more difficult problem in the case of massive leg edema. We have used 
multiple punctures, employing a regular hypodermic needle, inserted through a cork 
to permit the proper depth of penetration. The sites of puncture should first be prepared 
with a local anesthetic and strict asepsis should be maintained. We have also success-
fully employed a method employing the introduction of small lengths of polyethelene 
tubing which are placed through an 18 gauge thin wall needle that is then immediately 
withdrawn, leaving the tube in place. Several tubes can be placed at strategic points 
in an edematous extremity, but should probably not be allowed to remain more than 
twenty-four to forty-eight hours. Here again, asepsis is most important and antibiotics 
should probably be administered prophylactically to combat the possibility of infection. 
We have not found the hgation of the inferior vena cava to be a useful procedure in 
the management of our patients to date, although there are several reports in the 
literature which advocate this procedure." Wirringer suggests that it is an especially 
useful procedure to employ preoperatively in certain cases of mitral stenosis possessing 
an increased risk because of their advanced state of failure.^' They suggest that this 
may be followed later under more favorable conditions by the commissurotomy per-
formed as a second stage procedure, in a more fully compensated heart. Lian and his 
associates state that the most favorable patients for this maneuver are those in whom 
stasis is limited to the lungs. A less favorable group are those with stasis both in the 
lungs and in the liver with the least favorable group being those with viscera stasis 
associated with edema. The operative mortality is high in the series quoted, amounting 
to 25%, with another author citing a 50% mortality within a six month period. The 
advocates of this procedure claim prophylaxis against emboli as another advantage 
and state that it also may be combined with lumbar sympathectomy. 
' G. D. Searle and Co. 
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SUMMARY 
Various etiological factors important, not only as the primary causative condition 
but also as aggravating factors in cases of resistant cardiac failure are reviewed and 
possible therapeutic approaches to the problem are discussed. Special mention is made 
of the difficulty in diagnosing with certainty, the various disordered electrolyte patterns. 
It is felt that special emphysis should be given to the correction of hypoproteinemia 
when it exists and that steroids and anticoagulants show exceptional promise in many 
cases. The results with radioactive iodine are, in general, somewhat disappointing 
and the use of Aldosterone antagonists will require further evaluation before their 
ultimate usefullness is established. 
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